Literature DB >> 14688143

Relationship between Candida albicans virulence during experimental hematogenously disseminated infection and endothelial cell damage in vitro.

Angela A Sanchez1, Douglas A Johnston, Carter Myers, John E Edwards, Aaron P Mitchell, Scott G Filler.   

Abstract

Candida albicans must penetrate the endothelial cell lining of the vasculature to invade the deep tissues during a hematogenously disseminated infection. We compared 27 C. albicans mutants with their wild-type parent for their capacity to damage endothelial cells in vitro and cause a lethal infection in mice following tail vein inoculation. Of 10 mutants with significantly impaired capacity to damage endothelial cells, all had attenuated virulence. Therefore, the endothelial cell damage assay can be used as a screen to identify some virulence factors relevant to hematogenously disseminated candidiasis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14688143      PMCID: PMC344013          DOI: 10.1128/IAI.72.1.598-601.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  HWP1 functions in the morphological development of Candida albicans downstream of EFG1, TUP1, and RBF1.

Authors:  L L Sharkey; M D McNemar; S M Saporito-Irwin; P S Sypherd; W A Fonzi
Journal:  J Bacteriol       Date:  1999-09       Impact factor: 3.490

2.  Protein kinase A encoded by TPK2 regulates dimorphism of Candida albicans.

Authors:  A Sonneborn; D P Bockmühl; M Gerads; K Kurpanek; D Sanglard; J F Ernst
Journal:  Mol Microbiol       Date:  2000-01       Impact factor: 3.501

3.  RIM101-dependent and-independent pathways govern pH responses in Candida albicans.

Authors:  D Davis; R B Wilson; A P Mitchell
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

4.  Morphogenesis, adhesive properties, and antifungal resistance depend on the Pmt6 protein mannosyltransferase in the fungal pathogen candida albicans.

Authors:  C Timpel; S Zink; S Strahl-Bolsinger; K Schröppel; J Ernst
Journal:  J Bacteriol       Date:  2000-06       Impact factor: 3.490

5.  Secreted aspartyl proteinases and interactions of Candida albicans with human endothelial cells.

Authors:  A S Ibrahim; S G Filler; D Sanglard; J E Edwards; B Hube
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  Cloning and sequencing of a Candida albicans catalase gene and effects of disruption of this gene.

Authors:  D R Wysong; L Christin; A M Sugar; P W Robbins; R D Diamond
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

7.  Identification and characterization of TUP1-regulated genes in Candida albicans.

Authors:  B R Braun; W S Head; M X Wang; A D Johnson
Journal:  Genetics       Date:  2000-09       Impact factor: 4.562

8.  Filamentous growth of Candida albicans in response to physical environmental cues and its regulation by the unique CZF1 gene.

Authors:  D H Brown; A D Giusani; X Chen; C A Kumamoto
Journal:  Mol Microbiol       Date:  1999-11       Impact factor: 3.501

9.  Role of hyphal formation in interactions of Candida albicans with endothelial cells.

Authors:  Q T Phan; P H Belanger; S G Filler
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

10.  Reduced virulence of HWP1-deficient mutants of Candida albicans and their interactions with host cells.

Authors:  N Tsuchimori; L L Sharkey; W A Fonzi; S W French; J E Edwards; S G Filler
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

View more
  53 in total

1.  Genetic control of Candida albicans biofilm development.

Authors:  Jonathan S Finkel; Aaron P Mitchell
Journal:  Nat Rev Microbiol       Date:  2010-12-29       Impact factor: 60.633

2.  Requirement for Candida albicans Sun41 in biofilm formation and virulence.

Authors:  Carmelle T Norice; Frank J Smith; Norma Solis; Scott G Filler; Aaron P Mitchell
Journal:  Eukaryot Cell       Date:  2007-09-14

Review 3.  Alarmin(g) the innate immune system to invasive fungal infections.

Authors:  Alayna K Caffrey; Joshua J Obar
Journal:  Curr Opin Microbiol       Date:  2016-06-27       Impact factor: 7.934

Review 4.  Candida albicans-endothelial cell interactions: a key step in the pathogenesis of systemic candidiasis.

Authors:  Sarah E W Grubb; Craig Murdoch; Peter E Sudbery; Stephen P Saville; Jose L Lopez-Ribot; Martin H Thornhill
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

Review 5.  Glucose sensing network in Candida albicans: a sweet spot for fungal morphogenesis.

Authors:  Jeffrey Sabina; Victoria Brown
Journal:  Eukaryot Cell       Date:  2009-07-17

6.  Yeast and Filaments Have Specialized, Independent Activities in a Zebrafish Model of Candida albicans Infection.

Authors:  Brittany G Seman; Jessica L Moore; Allison K Scherer; Bailey A Blair; Sony Manandhar; Joshua M Jones; Robert T Wheeler
Journal:  Infect Immun       Date:  2018-09-21       Impact factor: 3.441

7.  SR-like RNA-binding protein Slr1 affects Candida albicans filamentation and virulence.

Authors:  Chaiyaboot Ariyachet; Norma V Solis; Yaoping Liu; Nemani V Prasadarao; Scott G Filler; Anne E McBride
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

8.  An internal polarity landmark is important for externally induced hyphal behaviors in Candida albicans.

Authors:  Alexandra Brand; Anjalee Vacharaksa; Catherine Bendel; Jennifer Norton; Paula Haynes; Michelle Henry-Stanley; Carol Wells; Karen Ross; Neil A R Gow; Cheryl A Gale
Journal:  Eukaryot Cell       Date:  2008-02-15

9.  Dispersion as an important step in the Candida albicans biofilm developmental cycle.

Authors:  Priya Uppuluri; Ashok K Chaturvedi; Anand Srinivasan; Mohua Banerjee; Anand K Ramasubramaniam; Julia R Köhler; David Kadosh; Jose L Lopez-Ribot
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

10.  Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice.

Authors:  Lin Lin; Ashraf S Ibrahim; Xin Xu; Joshua M Farber; Valentina Avanesian; Beverlie Baquir; Yue Fu; Samuel W French; John E Edwards; Brad Spellberg
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.